✦ LIBER ✦

Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial

✍ Scribed by Philipp Harter; Andreas du Bois; Maik Hahmann; Annette Hasenburg; Alexander Burges; Sibylle Loibl; Martina Gropp; Jens Huober; Daniel Fink; Willibald Schröder; Karsten Muenstedt; Barbara Schmalfeldt; Guenter Emons; Jacobus Pfisterer; Kerstin Wollschlaeger; Hans-Gerd Meerpohl; Georg-Peter Breitbach; Berno Tanner; Jalid Sehouli

Book ID: 111771721
Publisher: Springer
Year: 2006
Tongue: English
Weight: 294 KB
Volume: 13
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-006-9058-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic and predictive value of the A

Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer

✍ Harter, Philipp; Beutel, Bianca; Alesina, Piero F.; Lorenz, Dietmar; Boergers, A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Cisplatin/paclitaxel vs. carboplatin/pac

Cisplatin/paclitaxel vs. carboplatin/paclitaxel in 798 patients with ovarian cancer FIGO IIB-IV — Randomized phase III study the AGO (Arbeitsgemeinschaft Gynaekologische Onkologie) study group (OVAR-3 trial)

✍ Costa, S.D.; du Bois, A.; Lueck, H.J.; Meier, W.; Moebus, V.; Bauknecht, T.; Ric 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Impact of age on outcome in patients wit

Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)

✍ Pauline Wimberger; Nils Lehmann; Rainer Kimmig; Alexander Burges; Werner Meier; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Prognostic factors for complete debulkin

Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)

✍ Pauline Wimberger; Nils Lehmann; Rainer Kimmig; Alexander Burges; Werner Meier; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Topotecan versus treosulfan, an alkylati

Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)

✍ Werner Meier; Andreas du Bois; Alexander Reuss; Walther Kuhn; Sigrid Olbricht; M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 545 KB

929 POSTER Pre-operative selection crite

929 POSTER Pre-operative selection criteria for operability in recurrent ovarian cancer. a study of the AGO organkommission ovar and the AGO ovarian cancer study group (AGO-OVAR)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 277 KB